Smiling man wearing salmon-colored shirt

Starting Taltz has never been easier

Hypothetical Patient

Starting Taltz has never been easier

Taltz Savings Card

For eligible, commercially insured patients

Access regardless of treatment history or formulary requirements for as little as $5 or $25 per month, for up to 24 months.* See below for Terms and Conditions. Governmental beneficiaries excluded, terms and conditions apply.

Text "Taltz" to 85099 to access savings and support or to activate your patient's savings card.

What are the steps to start a patient on Taltz?

Enrollment Forms

Start with a Taltz Enrollment Form, which serves as the Taltz prescription.

Adult Dermatology Enrollment Form

Pediatric Dermatology Enrollment Form

Adult Rheumatology Enrollment Form

For more information about Lilly’s privacy practices, please view the Lilly Privacy Statement and Consumer Health Privacy Notice

Digital Enrollment

Lilly Patient Support Provider Portal

With the Lilly Patient Support Provider Portal, office sites are able to digitally enroll patients in Lilly Support Services and utilize services to help with access and coverage assistance.

The Lilly Patient Support Provider Portal provides:

Simplified and easy-to-use digital enrollment process
Convenient electronic options to obtain patient Health Insurance Portability and Accountability Act (HIPAA) authorization signature
Ability to view real-time patient status information and case history for all patients enrolled by the office (fax, phone, or Provider Portal)
Enables HCP offices to receive reminder alerts for important tasks necessary to help patients start treatment as early as possible
Secure Messaging Feature allows users to communicate directly with Lilly Support Services regarding their cases and patients
Access eEligibility (electronic eligibility) or ePA (electronic prior authorization) services to confirm patients’ eligibility and coverage (summary of benefits)

Your patients can now enroll directly in Lilly Support Services^™ with the Lilly Together^™ app.

To get started, patients can search for “Lilly Together” in the App Store^® or on Google Play^™ to download the app.

Once signed in, patients can:

Access their savings card information directly through the app so it's always with them.
Use symptom tracking to help them understand progress and stay on treatment, and give you a view of their symptom information all in one place the next time you meet.
Connect with a Companion in Care^™ team member for ongoing support.^*
Browse resources all inside the app.
Use the plan feature to set up their dosing plan and schedule dosing reminders to help them stay on track, when applicable.
Access injection logging to track doses over time, when applicable.

Office sites will be able to digitally enroll patients in Lilly Support Services and utilize services to help with access and coverage assistance.

^*Your Companion in Care provided is not a medical professional.

Lilly Support Services Offerings include:

Insurance Investigation

Help with preliminary insurance investigation and specialty pharmacy identification

Injection Training

Free of charge to patients and caregivers
Patients can choose either in-person or telephone training
Injection training videos available here, or through the Lilly Together^™ app

Ongoing Support

A personal patient resource to help answer questions or concerns
Help is available Monday-Friday from 8 AM to 10 PM ET
Available for patients who use the Lilly Together^™ app

Field Reimbursement Support

The Field Reimbursement Manager is an experienced access professional who can help your patients navigate the complex access and reimbursement environment.

The Field Reimbursement Managers are:

Knowledgeable: understand Lilly Support Services services, access challenges, and affordability options
Connected: integrated with the Lilly Support Services call center and understand the Taltz contracted specialty pharmacy network
Patient Focused: committed to providing information to support patient access to Taltz

Sharps Container Support

Allows patients to safely dispose of Taltz sharps in an FDA-cleared sharps disposal container. Once the container is full, your patient should put the container lid on and follow the patient community guidelines for the right way to dispose of their sharps disposal container. Sharps containers should not be recycled. Your patient can contact Lilly Support Services to receive another one.

**Eligible, commercially insured patients who are taking Taltz and are also prescribed Zepbound® (tirzepatide) Injection may be eligible to pay as little as $30 per month for both products^*†**

Patients can pay as little as $5 for Taltz and $25 for Zepbound per month. Taltz must be covered by the patient’s commercial drug insurance plan and the patient must be filling their Taltz prescription. Additional terms, conditions, and limitations apply.

Additional terms, conditions, and limitations apply. Governmental beneficiaries excluded. See full terms and conditions below.

^†One month is defined as 28 days and 4 pens for Zepbound.

For patients to enroll in Zepbound Savings for Taltz Patients:

Ensure that your patient has been prescribed Zepbound and Taltz (independently) for an approved use consistent with FDA-approved product labeling
Confirm that your patient meets all Card Eligibility and Additional Requirements as set forth in the Zepbound Savings for Taltz Patients Savings Card. See terms and conditions below.
Eligible patients who are interested in learning more about the Zepbound Savings for Taltz Patients savings card, including how to enroll, should visit this page.
Patients must have filled their Taltz prescription within the preceding (a) 45 days of filling their Zepbound prescription if they were prescribed a 28-day supply of Taltz, (b) 90 days of filling their Zepbound prescription if they were prescribed a 56-day supply of Taltz, or (c) 110 days if they were prescribed an 84-day supply of Taltz.
Patients may be required to take additional steps to obtain the applicable savings. Failure to provide required information may result in not obtaining the applicable savings. Please contact 1-833-366-7157 for assistance or questions regarding this offering.

Please see Prescribing Information including Boxed Warning and Medication Guide for Zepbound. See Instructions for Use included with the Zepbound pen.

Terms and Conditions
By enrolling in the Zepbound Savings for Taltz Patients Savings Card Program (“Program”) and using the Zepbound Savings for Taltz Patients Savings Card (“Card”), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility:

(1.) You have been prescribed Zepbound^® (tirzepatide) for an approved use consistent with FDA approved product labeling;
(2.) You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE^®/CHAMPUS, or any state prescription drug assistance program
(3.) You are a resident of the United States or Puerto Rico; and
(4.) You are 18 years of age or older.

Zepbound Savings for Taltz Patients - Additional Requirements:

(1.) You have been prescribed Taltz^® (ixekizumab) for an approved use consistent with FDA approved product labeling;
(2.) You have commercial drug insurance that covers Taltz;
(3.) You have filled your Taltz prescription within the preceding (a) 45 days of filling your Zepbound prescription if you were prescribed a 28-day supply of Taltz, (b) 90 days of filling your Zepbound prescription if you were prescribed a 56-day supply of Taltz, or (c) 110 days if you were prescribed an 84-day supply of Taltz (“Taltz Fill Timeframe”);
(4.) You are enrolled in the Taltz Savings Card program; and
(5.) You meet all Card Eligibility requirements above.

Card Terms and Conditions

For patients with commercial drug insurance coverage for Zepbound whose Taltz prescription has been filled within the Taltz Fill Timeframe: In order to be eligible to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Zepbound, you must meet and comply with both the Card Eligibility and Zepbound Savings for Taltz Patients - Additional Requirements above. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $295 per 1-month prescription, $590 per 2-month prescription, or $885 per 3-month prescription fill and a separate maximum annual savings of up to $3,835 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Participation in the Program requires a valid patient HIPAA authorization. If you discontinue filling your Taltz prescription for any reason, you may use this Card on or before 12/31/2025 for a maximum of one additional prescription fill, to pay as little as $25 for a 1-month, 2-month, or 3-month supply of Zepbound. After you have utilized this one additional prescription fill of Zepbound following discontinuation of Taltz, you will no longer be eligible to use this Card. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2025.

For patients with commercial drug insurance who do not have coverage for Zepbound and whose Taltz prescription has been filled within the Taltz Fill Timeframe: In order to be eligible to pay as little as $25 for a 1-month prescription fill of Zepbound, you must meet and comply with both the Card Eligibility and Zepbound Savings for Taltz Patients - Additional Requirements above. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of $1,094 for one 28-day supply of Zepbound and a separate maximum annual savings of $14,222 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Participation in the Program requires a valid patient HIPAA authorization. If you discontinue filling your Taltz prescription for any reason, you may use this Card on or before 12/31/2025 for a maximum of one additional prescription fill, to pay as little as $25 for a 1-month supply of Zepbound. After you have utilized this one additional prescription fill of Zepbound following discontinuation of Taltz, you will no longer be eligible to use this Card. Subject to Lilly’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2025.

For patients with commercial drug insurance coverage for Zepbound and whose Taltz prescription has not been filled within the Taltz Fill Timeframe: If your Taltz prescription cannot be verified as having been filled within the Taltz Fill Timeframe or you otherwise do not meet the Zepbound Savings for Taltz Patients - Additional Requirements outlined above, you can pay as little as $25 for a 1- month, 2-month, or 3-month prescription fill of Zepbound. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $150 per 1-month prescription, $300 per 2-month prescription, or $450 per 3-month prescription fill and separate maximum annual savings of up to $1,950 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Participation in the Program requires a valid patient HIPAA authorization. Subject to Lilly’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2025.

For patients with commercial drug insurance who do not have coverage for Zepbound and whose Taltz prescription has not been filled within Taltz Fill Timeframe: If your Taltz prescription cannot be verified as having been filled within the Taltz Fill timeframe or you otherwise do not meet the Zepbound Savings for Taltz Patients - Additional Requirements outlined above, you can save up to $469 off your 1-month prescription fill of Zepbound. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $469 and a separate maximum annual savings of up to $6,097 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Participation in the Program requires a valid patient HIPAA authorization. Subject to Lilly’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 6/30/2025.

Post-Transaction Reimbursement

Savings may not be applied at the point of sale and may require further action from you to obtain the applicable savings. If you filled your Taltz prescription within the Taltz Fill Timeframe and otherwise meet the Card Eligibility and Zepbound Savings for Taltz Patients - Additional Requirements outlined above, but Lilly was not able to verify such at the point of sale, you may submit a claim for Post Transaction Reimbursement. A Post-Transaction Reimbursement claim may result in Lilly issuing you a reimbursement for the difference between what you paid and what you would have paid had Lilly been able to verify at the point of sale that your Taltz prescription had been filled within the Taltz Fill Timeframe. Claims for Post-Transaction Reimbursement must be submitted through the Program’s online patient reimbursement portal https://eversana-ptr.virtualrx.co or by mailing a completed claim form to Savings Card Post-Transaction Reimbursement, PO BOX 42638 Cincinnati, OH 45242 Attn: PTR Processing. For a copy of the claim form, please call 1-866-923-1953. A valid Post-Transaction Reimbursement claim must include: your name; date of birth; address; a copy of your primary insurance card; a copy of your original activated Zepbound Savings for Taltz Patients Savings Card information; original pharmacy receipt for your Zepbound prescription; a cash register receipt or Explanation of Benefit (EOB) for your Zepbound prescription; original pharmacy receipt for your Taltz prescription; and a cash register receipt or Explanation of Benefit (EOB) for your Taltz prescription. At its sole discretion, Lilly may request additional information to validate your claim for reimbursement and is not obligated or required to reimburse any amounts if the requested additional information is not provided. Claims for reimbursement must be submitted in the patient portal or postmarked by no later than March 31, 2026. Reimbursement claims are subject to program eligibility and terms and conditions, including Lilly's right to terminate, rescind, revoke, or amend the post-transaction reimbursement program at any time in Lilly's sole discretion, without notice, and for any reason.

Additional Terms and Conditions
If you have an insurance plan that is participating in an alternate funding program (“AFP”) that requires you to apply to the Zepbound Savings for Taltz Patients Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of Zepbound, you are not eligible for and are prohibited from using the Zepbound Savings for Taltz Patients Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member’s use of the Zepbound Savings for Taltz Patients Savings Card Program. You agree to inform the Zepbound Savings for Taltz Patients Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the applicable monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly’s sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for Zepbound, only allows partial coverage for Zepbound, removes coverage for Zepbound and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of Zepbound, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for Zepbound. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. Card activation is required. You may not seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Zepbound. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are nontransferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. THIS CARD IS NOT INSURANCE. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Lilly’s sole discretion to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions includes the right to terminate any individual Card if Lilly determines, in its sole discretion, that a patient does not satisfy the Card’s eligibility criteria or is using or has attempted to use the Card inconsistently with these terms and conditions. Eligibility criteria, and terms and conditions for the Zepbound Savings for Taltz Patients Savings Card Program may change from time to time; the most current version can be found at https://taltz.lilly.com/savings-support. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly’s right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2025.

Taltz Savings Card Terms and Conditions

By enrolling in the Taltz Savings Card Program (“Program”) and using the Taltz Savings Card (“Card”), you attest that you meet the eligibility criteria, agree to, and will comply with the terms and conditions described below:

Card Eligibility:

You have been prescribed Taltz^® (ixekizumab) for an approved use consistent with FDA approved product labeling;
You are enrolled in a commercial drug insurance plan;
You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE^®/CHAMPUS, or any state prescription drug assistance program;
You are a resident of the United States or Puerto Rico; and
You are 18 years of age or older.

Card Terms and Conditions:

For patients with commercial drug insurance coverage for Taltz: You must have commercial drug insurance that covers Taltz and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $5 for a 1-month prescription fill of Taltz. Month is defined as 28-days and up to 3 pens. Card must be first used by no later than 12/31/2025. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges and a separate maximum annual savings of up to $9,200 per calendar year. Card may be used for a maximum of up to 14 prescription fills per calendar year and a separate maximum of up to 24 prescription fills over the lifetime of the Program, subject to the previously stated maximum monthly and annual savings limit. Except where prohibited by applicable state law, Card monthly and annual savings are reduced if Lilly identifies that you are enrolled in a plan or program, sometimes called a maximizer plan, that adjusts your cost sharing amount to be equal to or include some portion of the savings provided by the Card and attempts to prevent the savings from this Card from being applied to your out-of-pocket costs, including but not limited to copayments, coinsurances, and deductibles (“Maximizer”). If the Program identifies you are enrolled in a Maximizer, Card savings are reduced to a maximum annual savings of up to $7,000 per calendar year. If you have reason to believe that the Program erroneously identified enrollment in a Maximizer, please call the Taltz Savings Card Program at 1-800-LillyRx (1-800-545-5979). Participation in the Program requires a valid patient HIPAA authorization upon enrollment into the Program. Subject to Lilly USA, LLC's right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2027 or 24 months after you first use the Card, whichever comes first.

For patients with commercial drug insurance who do not have coverage for Taltz: You must have commercial drug insurance that does not cover Taltz and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $25 for a 1-month supply of Taltz. Month is defined as 28-days and up to 3 pens. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges, up to a maximum of 14 prescription fills per calendar year and a separate maximum of up to 24 prescription fills over the lifetime of the Program. Card must be first used by no later than 12/31/2025. Participation in the Program requires submission of a prior authorization (PA) prior to the first prescription fill. If coverage is denied, an appeal must be submitted prior to 5th month prescription fill. To remain eligible for the Program, a new PA, appeal, or medical exception must be submitted prior to the 13th prescription fill and as required by Lilly at its sole discretion. Participation in the Program requires a valid patient HIPAA authorization to remain in the Program. Subject to Lilly USA, LLC's right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions, which may occur at Lilly's sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2027 or 24 months after you first use the Card, whichever comes first.

Additional Program Terms and Conditions

If you have an insurance plan that is participating in an alternate funding program (“AFP”) that requires you to apply to the Taltz Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of Taltz, you are not eligible for and are prohibited from using the Taltz Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member's use of Taltz Savings Card Program. You agree to inform Taltz Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the applicable monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly's sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for Taltz, only allows partial coverage for Taltz, removes coverage for Taltz and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of Taltz, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for Taltz. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. If at any time you begin receiving drug coverage under any state, federal, or government funded healthcare program, you understand that you will no longer be eligible for the Taltz Savings Card and agree to call the Taltz Savings Card Program at 1-800-LillyRx (1-800-545-5979) to stop participation. Card activation is required. You may not seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Taltz. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are nontransferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. THIS CARD IS NOT INSURANCE. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Lilly's sole discretion to terminate, rescind, revoke, or amend Card eligibility and/or Card terms and conditions includes the right to terminate any individual Card if Lilly determines, in its sole discretion, that a patient does not satisfy the Card's eligibility criteria or is using or has attempted to use the Card inconsistently with these terms and conditions. Eligibility criteria, and terms and conditions for the Taltz Savings Card Program may change from time to time; the most current version can be found at https://www.taltz.lilly.com/savings-support. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly's right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions, which may occur at Lilly's sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2027 or 24 months after you first use the Card, whichever comes first.

TRICARE^® is a registered trademark of the Department of Defense (DoD), DHA.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS:

Taltz is contraindicated in patients with a previous serious hypersensitivity reaction, such as anaphylaxis, to ixekizumab or to any of the excipients.

WARNINGS AND PRECAUTIONS

Infections
Taltz may increase the risk of infection. Serious infections have occurred. In clinical trials of adult patients with plaque psoriasis, the Taltz group had a higher rate of infections than the placebo group (27% vs 23%). A similar increase in risk of infection was seen in placebocontrolled trials of adult patients with psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and pediatric patients with plaque psoriasis. In the post-marketing setting, serious bacterial, viral, and fungal opportunistic infections have been reported in patients receiving IL-17 inhibitors, including Taltz. Instruct patients to seek medical advice if signs or symptoms of clinically important chronic or acute infection occur. If a patient develops a serious infection or is not responding to standard therapy, monitor the patient closely and discontinue Taltz until the infection resolves.

Pre-Treatment Evaluation for Tuberculosis
Evaluate patients for tuberculosis (TB) infection prior to initiating treatment with Taltz. Do not administer to patients with active TB infection. Initiate treatment of latent TB prior to administering Taltz. Consider anti-TB therapy prior to initiating Taltz in patients with a past history of latent or active TB in whom an adequate course of treatment cannot be confirmed. Patients receiving Taltz should be monitored closely for signs and symptoms of active TB during and after treatment.

Hypersensitivity
Serious hypersensitivity reactions, including angioedema and urticaria (each ≤0.1%), occurred in the Taltz group in clinical trials. Anaphylaxis, including cases leading to hospitalization, has been reported in post-marketing use with Taltz. If a serious hypersensitivity reaction occurs, discontinue Taltz immediately and initiate appropriate therapy.

Eczematous Eruptions
In the postmarketing setting, cases of severe eczematous eruptions, including atopic dermatitis-like eruptions, dyshidrotic eczema, and erythroderma were reported in patients receiving Taltz; some cases resulted in hospitalization. The onset of eczematous eruptions was variable, ranging from days to months after the first dose of Taltz. Treatment may need to be discontinued to resolve the eczematous eruption. Some patients with limited psoriasis treatment options were successfully treated for eczema while continuing Taltz.

Inflammatory Bowel Disease
Patients treated with Taltz may be at an increased risk of inflammatory bowel disease. In clinical trials, Crohn's disease and ulcerative colitis, including exacerbations, occurred at a greater frequency in the Taltz group than the placebo group. During Taltz treatment, monitor patients for onset or exacerbations of inflammatory bowel disease and if IBD occurs, discontinue Taltz and initiate appropriate medical management.

Immunizations
Prior to initiating therapy with Taltz, consider completion of all age-appropriate immunizations according to current immunization guidelines. Avoid use of live vaccines in patients treated with Taltz.

ADVERSE REACTIONS

Most common adverse reactions (≥1%) associated with Taltz treatment are injection site reactions, upper respiratory tract infections, nausea, and tinea infections. Overall, the safety profiles observed in adult patients with psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and pediatric patients with plaque psoriasis were consistent with the safety profile in adult patients with plaque psoriasis, with the exception of influenza and conjunctivitis in psoriatic arthritis and conjunctivitis, influenza, and urticaria in pediatric psoriasis.

Please see Prescribing Information and Medication Guide. Please see Instructions for Use included with the device.

Taltz is available as an 80 mg/mL, 40 mg/0.5mL, 20 mg/0.25mL injection.

IX HCP ISI 20AUG2024

INDICATIONS

Taltz is indicated for adults with active psoriatic arthritis (PsA), for adults with active ankylosing spondylitis (AS), and for adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation. Taltz is also indicated for patients aged 6 years or older with moderateto-severe plaque psoriasis (PsO) who are candidates for systemic therapy or phototherapy.

Taltz Savings Card

For eligible, commercially insured patients

Access regardless of treatment history or formulary requirements for as little as $5 or $25 per month, for up to 24 months.* See below for Terms and Conditions. Governmental beneficiaries excluded, terms and conditions apply.

Text "Taltz" to 85099 to access savings and support or to activate your patient's savings card.

What are the steps to start a patient on Taltz?

Access Taltz through a specialty pharmacy that is convenient for patients.

Prior Authorization Outcome:

Approved:

Denied:

Services

Enrollment Forms